Gengos Andrew 4
4 · Athira Pharma, Inc. · Filed Jun 9, 2023
Insider Transaction Report
Form 4
Gengos Andrew
See Below
Transactions
- Purchase
Common Stock
2023-06-07$3.44/sh+11,719$40,308→ 80,012 total - Purchase
Common Stock
2023-06-07$3.40/sh+2,859$9,721→ 68,293 total - Purchase
Common Stock
2023-06-07$3.36/sh+422$1,417→ 65,434 total
Footnotes (2)
- [F1]The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares purchased. These shares were purchased in multiple transactions at prices ranging from $3.355 to $3.36, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.
- [F2]The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares purchased. These shares were purchased in multiple transactions at prices ranging from $3.43 to $3.44, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.